Inventor
PHADKE AVINASH S
US49 patents
⚠️ This page may combine multiple inventors who share the name “PHADKE AVINASH S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ACHILLION PHARMACEUTICALS INC
47 patentsUS10550140B2Feb 4, 2020
Ether compounds for treatment of complement mediated disorders
ACHILLION PHARMACEUTICALS INC27 citations98
US10464956B2Nov 5, 2019
Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
ACHILLION PHARMACEUTICALS INC21 citations98
US10428094B2Oct 1, 2019
Amide compounds for treatment of complement mediated disorders
ACHILLION PHARMACEUTICALS INC21 citations98
US10428095B2Oct 1, 2019
Compounds for treatment of complement mediated disorders
ACHILLION PHARMACEUTICALS INC21 citations98
US10370394B2Aug 6, 2019
Carbamate, ester, and ketone compounds for treatment of complement mediated disorders
ACHILLION PHARMACEUTICALS INC23 citations98
US10253053B2Apr 9, 2019
Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
ACHILLION PHARMACEUTICALS INC22 citations98
US10189869B2Jan 29, 2019
Amino compounds for treatment of complement mediated disorders
ACHILLION PHARMACEUTICALS INC27 citations98
US10106563B2Oct 23, 2018
Ether compounds for treatment of complement mediated disorders
ACHILLION PHARMACEUTICALS INC30 citations98
US10087203B2Oct 2, 2018
Compounds for treatment of complement mediated disorders
ACHILLION PHARMACEUTICALS INC25 citations98
US10081645B2Sep 25, 2018
Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
ACHILLION PHARMACEUTICALS INC27 citations98
US10005802B2Jun 26, 2018
Amide compounds for treatment of complement mediated disorders
ACHILLION PHARMACEUTICALS INC27 citations98
US9828396B2Nov 28, 2017
Alkyne compounds for treatment of complement mediated disorders
ACHILLION PHARMACEUTICALS INC30 citations98
US9796741B2Oct 24, 2017
Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
ACHILLION PHARMACEUTICALS INC37 citations98
US9758537B2Sep 12, 2017
Compounds for treatment of complement mediated disorders
ACHILLION PHARMACEUTICALS INC27 citations98
US9732104B2Aug 15, 2017
Ether compounds for treatment of complement mediated disorders
ACHILLION PHARMACEUTICALS INC30 citations98
US9732103B2Aug 15, 2017
Carbamate, ester, and ketone compounds for treatment of complement mediated disorders
ACHILLION PHARMACEUTICALS INC32 citations98
US9695205B2Jul 4, 2017
Amide compounds for treatment of complement mediated disorders
ACHILLION PHARMACEUTICALS INC32 citations98
US9663543B2May 30, 2017
Phosphonate compounds for treatment of complement mediated disorders
ACHILLION PHARMACEUTICALS INC32 citations98
US9598446B2Mar 21, 2017
Amino compounds for treatment of complement mediated disorders
ACHILLION PHARMACEUTICALS INC33 citations98
US11407738B2Aug 9, 2022
Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders
ACHILLION PHARMACEUTICALS INC16 citations94
US11084800B2Aug 10, 2021
Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders
ACHILLION PHARMACEUTICALS INC18 citations94
US11053253B2Jul 6, 2021
Macrocyclic compounds for treatment of medical disorders
ACHILLION PHARMACEUTICALS INC16 citations94
US10919884B2Feb 16, 2021
Amide compounds for treatment of immune and inflammatory disorders
ACHILLION PHARMACEUTICALS INC20 citations94
US10906887B2Feb 2, 2021
Amino compounds for treatment of immune and inflammatory disorders
ACHILLION PHARMACEUTICALS INC20 citations94
US10822352B2Nov 3, 2020
Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders
ACHILLION PHARMACEUTICALS INC20 citations94
US10662175B2May 26, 2020
Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders
ACHILLION PHARMACEUTICALS INC20 citations94
US10385097B2Aug 20, 2019
Ether compounds for treatment of medical disorders
ACHILLION PHARMACEUTICALS INC23 citations94
US10287301B2May 14, 2019
Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders
ACHILLION PHARMACEUTICALS INC28 citations94
US10138225B2Nov 27, 2018
Amide compounds for treatment of medical disorders
ACHILLION PHARMACEUTICALS INC33 citations94
US10092584B2Oct 9, 2018
Compounds for the treatment of medical disorders
ACHILLION PHARMACEUTICALS INC28 citations94
US10011612B2Jul 3, 2018
Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders
ACHILLION PHARMACEUTICALS INC30 citations94
US10000516B2Jun 19, 2018
Phosphonate compounds for treatment of medical disorders
ACHILLION PHARMACEUTICALS INC28 citations94
US12065459B2Aug 20, 2024
Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
ACHILLION PHARMACEUTICALS INC3 citations86
US11708351B2Jul 25, 2023
Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders
ACHILLION PHARMACEUTICALS INC8 citations86
US11447465B2Sep 20, 2022
Pharmaceutical compounds for treatment of medical disorders
ACHILLION PHARMACEUTICALS INC16 citations86
US11001600B2May 11, 2021
Disubstituted compounds for treatment of medical disorders
ACHILLION PHARMACEUTICALS INC16 citations86
US10807952B2Oct 20, 2020
Compounds for treatment of immune inflammatory disorders
ACHILLION PHARMACEUTICALS INC20 citations86
US10660876B2May 26, 2020
Amino compounds for treatment of medical disorders
ACHILLION PHARMACEUTICALS INC20 citations86
US12006307B2Jun 11, 2024
Pharmaceutical compounds for treatment of medical disorders
ACHILLION PHARMACEUTICALS INC3 citations75
US12162860B2Dec 10, 2024
Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders
ACHILLION PHARMACEUTICALS INC2 citations73
US12139497B2Nov 12, 2024
Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders
ACHILLION PHARMACEUTICALS INC1 citations73
US11718626B2Aug 8, 2023
Macrocyclic compounds for treatment of medical disorders
ACHILLION PHARMACEUTICALS INC3 citations73
US11649223B2May 16, 2023
Amino compounds for treatment of immune and inflammatory disorders
ACHILLION PHARMACEUTICALS INC3 citations73
US11649229B2May 16, 2023
Amide compounds for treatment of immune and inflammatory disorders
ACHILLION PHARMACEUTICALS INC3 citations73
US12338230B2Jun 24, 2025
Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders
ACHILLION PHARMACEUTICALS INC0 citations63
US11926617B2Mar 12, 2024
Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders
ACHILLION PHARMACEUTICALS INC0 citations63
US12297205B2May 13, 2025
Macrocyclic compounds for treatment of medical disorders
ACHILLION PHARMACEUTICALS INC0 citations62